Related
Technology Description

The present invention describes a biosensor for the detection of DNA of C. auris and/or diagnosis of infection caused by this new and multi-resistant species of pathogenic fungus that solves the problems of the devices and methods of the state of the art.
This innovative technology allows a fast and easy detection of C. auris with a high level of sensitivity and selectivity. Based on this biosensor, a detection method and a method of diagnosing diseases caused by said pathogenic fungus have also been developed.
The biosensor is based on a porous material that comprises an indicator and single-stranded DNA oligonucleotides that specifically recognize a region of Candida auris DNA. When the Candida auris is present in the medium, the oligonucleotides recognize that DNA region of the fungus, bind to it, and the release of an indicator by which the fungus can be detected occurs.
This method allows a fast and easy detection of C. auris with a high level of sensitivity and selectivity.
No specialized personnel are required, this is a simple method of detection by direct visual observation of the medium.
Detection and / or quantification of diagnosis are carried out in one hour, reducing the time of tests used routinely.
The in vitro diagnostic method developed is suitable for detecting and/or quantifying C. auris in samples from subjects infected with the fungus. Subjects are human, but can also be animals, preferably mammals.
Clinical samples suitable for the use of the invention are: body fluids, such as blood, serum, sputum, pleural fluid, peritoneal fluid, synovial fluid, and cerebrospinal fluid.
A Kit has been prepared comprising biosensor, buffers, delivery vehicles, material supports, positive and/or negative control components, and use instructions.

Potential Benefits

This innovative technology allows a fast and easy detection of Candida auris with a high level of sensitivity and selectivity. Based on this biosensor, a detection method and a method of diagnosing diseases caused by said pathogenic fungus have also been developed.

Limitations

To be determined during further development.

Suggested Applications

Patient need adressed:
Infection of candida auris
(Candidemia, Candidiasis)

Case manager

Aida Castellanos Paez

Status
Spanish patent application (Priority date: April 27, 2020). Suitable for international extension (PCT application)
Availability
Licensing or Assignment
Inventor(s)
Sara Santiago, Luis Pla, Ma. Angeles Tormo, Elena Aznar, Alba Cecilia Ruiz, Eulogio Valentin, Javier Peman, Ramon Martinez

Centro de Investigación Biomédica en Red, Bioingeniería, Biomateriales y Nanomedicina

Discover the institution >>
The Biomedical Networking Research Center of Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN) is one of the 11 thematic areas of CIBER. CIBER groups some of the main Spanish research groups (more than 400) in biomedicine, located in more than 100 institutions distributed around Spain. Website: http://www.ciber-bbn.es/
The technological areas
Life sciences, Medicine

Technology Readiness Level 3

Interested in being updated as to the helpdesk's activities?

By subscribing to the Newsletter, you will get constant updates about:

  • available technologies
  • recent changes in IP law
  • webinars and seminars
  • articles and presentations
Subscribe